Merck (MRK) Long-Term Deferred Tax (2010 - 2023)

Merck (MRK) has 14 years of Long-Term Deferred Tax data on file, last reported at $10.2 billion in Q2 2023.

• Quarterly Long-Term Deferred Tax fell 7.15% year-over-year to $10.2 billion in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $10.2 billion (down 7.15% YoY) and the FY2022 annual result came in at $9.5 billion, down 17.73% from the prior year.
• Long-Term Deferred Tax slipped to $10.2 billion in Q2 2023 per MRK's latest filing, from $10.3 billion in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $11.6 billion in Q4 2021 and bottomed at $6.8 billion in Q4 2019.
• The 5-year median for Long-Term Deferred Tax is $9.7 billion (2020), against an average of $9.6 billion.
• The widest annual swing landed in 2020, when Long-Term Deferred Tax fell 19.01%; it then soared 48.7% in 2021.
• Tracing MRK's Long-Term Deferred Tax over 5 years: stood at $6.8 billion in 2019, then jumped by 45.93% to $9.9 billion in 2020, then gained by 17.21% to $11.6 billion in 2021, then fell by 17.73% to $9.5 billion in 2022, then rose by 6.92% to $10.2 billion in 2023.
• Per Business Quant, the three latest MRK Long-Term Deferred Tax figures stand at $10.2 billion (Q2 2023), $10.3 billion (Q1 2023), and $9.5 billion (Q4 2022).

Peer Comparison